An internal standard for the quantification of flavoxate
Related Products
Labeled Version(s)
33816Flavoxate-d5
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Flavoxate (hydrochloride)

Item No. 19096

Technical Information
Formal Name
3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester, monohydrochloride
CAS Number
3717-88-2
Synonyms
  • NSC 114649
  • Rec 7/0040
Molecular Formula
C24H25NO4 • HCl
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 1 mg/mlDMF:PBS(pH 7.2)(1:1): 0.5 mg/mlDMSO: 1 mg/ml
λmax
241, 289, 316 nm
SMILES
CC1=C(C2=CC=CC=C2)OC3=C(C(OCCN4CCCCC4)=O)C=CC=C3C1=O.Cl
InChi Code
InChI=1S/C24H25NO4.ClH/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25;/h2,4-5,8-12H,3,6-7,13-16H2,1H3;1H
InChi Key
XOEVKNFZUQEERE-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Flavoxate is an inhibitor of L-type calcium channels and an antimuscarinic agent.1 It induces relaxation of potassium-precontracted isolated human urinary bladder detrusor muscle (IC50 = 2 µM) and reduces contractions induced by the acetylcholine receptor agonist carbachol (carbamoylcholine; Item No. 14486) or calcium in isolated rat detrusor strips.1,2 Microinjection of flavoxate (0.68 µg/animal) into the oral pontine reticular nucleus inhibits reflex micturition in decerebrated cats, and intravenous or intracerebroventricular administration reduces isovolumetric rhythmic bladder contractions in rats.2 Formulations containing flavoxate have previously been used in the treatment of frequent or urgent urination, increased nocturnal urination, bladder pain, and urinary incontinence.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Tomoda, T., Aishima, M., Takano, N., et alThe effects of flavoxate hydrochloride on voltage-dependent L-type Ca2+ currents in human urinary bladder. Brit. J. Pharmacol. 146(1), 25-32 (2005).

    2. Kimura, Y., Sasaki, Y., Hamada, K., et alMechanisms of the suppression of the bladder activity by flavoxate. Int. J. Urol. 3(3), 218-227 (1996).